Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1608, 2007-01, pp. : 2-2
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Fluoroquinolone use a risk factor for CDAD
Reactions Weekly, Vol. 1, Iss. 1084, 2006-01 ,pp. :
Costs for branded drugs up, generics down in US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 625, 2011-01 ,pp. :
Thumbs up and thumbs down in the arena of science
By Eaton J.W.
Redox Report, Vol. 5, Iss. 1, 2000-02 ,pp. :
CDAD increases short- and long-term costs in nonsurgical patients
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 546, 2008-01 ,pp. :
Step-up strategy better choice than step-down in dyspepsia
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 570, 2009-01 ,pp. :